“☎[광고텔레:ADSFIX01] 룸싸롱홍보 찌라시홍보 구글010광고 휴게텔홍보 파워볼홍보 법인통장업체 마케팅홍보 구글노래방광고 구글상단도배광고 구글1페이지광고☎”的搜索结果，显示 31-40 项，共有 12289 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in ...

4. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this study is to establish a registry that will address the data gap regarding the course of NSTEMI (Non-ST-Elevation Myocardial Infarction) ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 肾上腺癌- 医生与科室- 妙佑医疗国际

   了解这种起源于肾上腺的罕见癌症，以及其症状、诊断和治疗（包括肾上腺切除术）。

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

9. 乳腺专科门诊 - 临床试验 - 妙佑医疗国际

   Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with breast conditions.

10. 神经科- 临床试验- 妙佑医疗国际

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...